
Gold Royalty Corp.: Exploration Success Continues At Key Royalty Assets (NYSE:GROY)
Elena Bionysheva-Abramova/iStock via Getty Images The Q3 Earnings Season has come to an end and…
Elena Bionysheva-Abramova/iStock via Getty Images The Q3 Earnings Season has come to an end and one of the first companies to report its results was Gold Royalty Corporation (NYSE:GROY). Overall, the company had a better quarter sequentially with a lower adjusted net loss and much higher total revenue and land agreement proceeds, as well as…
Love Employee/iStock via Getty Images Topline Summary Immix Biopharma (NASDAQ:IMMX) is a biotech company focused on development of novel CAR-T and other cell-based therapies for cancers and heme disorders. They are joining a growing group of companies using natural killer cell-based immunotherapy, which remains promising but unproven. Still, IMMX has a bit more data than…
Alasdair Jones SSE plc (OTCPK:SSEZF), a UK-based utility company with an integrated presence in regulated electricity networks and renewable energy generation, has come a long way since its public battle with activist investor Elliott in 2021. In recent months, SSE has continued to make headway in disproving the notion that a renewables business needs to…
porcorex Despite expectations of some major post-Thanksgiving launches, just two small Asian issuers listed in the US this past week. Hong Kong-based financial services firm Garden Stage (GSIW) offered more shares and priced at the low end to raise $10 million at a $64 million market cap. Through its subsidiaries, the company provides placement and…
Ake Ngiamsanguan/iStock via Getty Images Mistras Group (NYSE:MG) offers asset protection solutions. MG posted Q3 FY23 results, which I will analyze in this report. I think MG is not a buy right now. Due to increasing debt, stagnant revenue growth, and because of the technical chart. It would be risky to bet on MG right…
PPAMPicture/E+ via Getty Images CION Investment (NYSE:CION) has been a relatively under-the-radar middle-market business development company since going public in 2021. The externally managed BDC primarily invests in first lien senior secured loans with total investments at fair value of $1.73 billion across 109 portfolio companies as of the end of its fiscal 2023 third…
anusorn nakdee BioLineRx Ltd. (NASDAQ:BLRX) is a biopharmaceutical company founded in 2003 with headquarters in Israel and offices in the US. BLRX’s shares are traded in NASDAQ and TASE. Notably, BLRX has developed Aphexda, motixafortide for injection, the first drug FDA-approved for stem cell mobilization in multiple myeloma patients in a decade. The FDA approved…
Joe Hendrickson/iStock Editorial via Getty Images Duluth Holdings Inc. (NASDAQ:DLTH) has struggled through a challenging macro environment in recent years amid declining sales and poor earnings. The apparel retailer just reported its latest quarterly result, which missed estimates while management offered soft guidance. The setup here doesn’t look good with the stock down more than…
da-kuk Palo Alto Networks’ (NASDAQ:PANW) Q1 FY2024 results were somewhat soft, with NGS growth beginning to moderate and hardware sales normalizing. The company remains well positioned though, due to its large customer base and broad portfolio of solutions. In particular, XSIAM and SASE should drive growth going forward. The stock is starting to look fully…
Daniel Boczarski/Getty Images Entertainment Regardless of how your own personal financial situation might be, the fact of the matter is that the economy is currently being impacted by high inflation and high interest rates aimed at combating that inflation. Naturally, during times of difficulty, one of the first things that consumers tend to cut back…